Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
AURANOFIN bulk supplier for pharma manufacturers

Auranofin 3 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 3 mg

Reference Brands: Ridaura (USA)

Category: Immune Disorder

Auranofin is a Immune Disorder product available as Capsules in strengths 3 mg. It corresponds to the reference brand Ridaura (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Auranofin, marketed under the brand name Ridaura, is an orally administered gold-containing compound classified by the World Health Organization as an antirheumatic agent. It is primarily used in the management of rheumatoid arthritis, a chronic autoimmune condition characterized by joint inflammation, pain, and progressive joint damage.

As one of only two gold compounds still employed in modern medicine, alongside sodium aurothiomalate, auranofin works by modulating the immune system and reducing inflammatory responses. It inhibits certain immune pathways and decreases the activity of inflammatory cells, helping to control joint swelling, tenderness, and stiffness.

Administered orally as a 3 mg capsule, auranofin offers a convenient treatment option for long-term management of rheumatoid arthritis. Regular monitoring is recommended during therapy to detect potential side effects, which may include gastrointestinal discomfort, skin reactions, or hematologic changes. Through its targeted immunomodulatory activity, Ridaura remains a valuable therapeutic option for patients requiring disease-modifying antirheumatic treatment, supporting improved joint function and quality of life.

Auranofin — third party manufacturing & bulk supply

Auranofin 3 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Auranofin is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Auranofin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Auranofin →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Auranofin is used to treat rheumatoid arthritis, helping reduce joint pain, swelling, and inflammation.

Auranofin is a gold-containing compound formulated as oral capsules for systemic anti-inflammatory and immune-modulating activity.

The trade name of auranofin is Ridaura.

Auranofin (Ridaura) is manufactured and marketed by GlaxoSmithKline.

The generic name of Auranofin is auranofin.

The brand name of Auranofin is Ridaura.

Auranofin (Ridaura) is manufactured in FDA-approved facilities in the United States for GlaxoSmithKline.

Related Products

Etrasimod Arginine

Strength:
2 mg, 4 mg, 6 mg

Form: Tablets

Reference Brands: Velsipity (USA)

View Details
Avacopan

Strength:
10 mg

Form: Capsules

Reference Brands: Tavneos (USA/EU)

View Details
Fostamatinib Disodium

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Tavalisse (USA)

View Details
Deucravacitinib

Strength:
6 mg

Form: Tablet

Reference Brands: Sotyktu (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.